Evidence map›Paper›PMID 33123166›Full record

ReviewFrontiers in immunology2020

Neuropeptide Y Is an Immunomodulatory Factor: Direct and Indirect.

Wei-Can Chen, Yi-Bin Liu, Wei-Feng Liu, Ying-Ying Zhou, He-Fan He, Shu Lin

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 111 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Neuropeptide Y as a Neuro-Immune Checkpoint in Cancer.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2026
    Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Integrative phytochemical profiling andFrontiers in nutrition · 2026
    Article
  13. Review
  14. The liver talks back: NPY orchestrates attraction of cancer cells and CHK2-dependent clonogenicity in the metastatic niche.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Investigation of the Immunomodulatory and Neuroprotective Properties ofInternational journal of molecular sciences · 2025
    Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Wei-Can ChenDepartment of Anesthesiology, The Second Affiliated Hospital, Fujian Medical University, Quanzhou, China.
Yi-Bin LiuDepartment of Anesthesiology, The Second Affiliated Hospital, Fujian Medical University, Quanzhou, China.
Wei-Feng LiuDepartment of Anesthesiology, The Second Affiliated Hospital, Fujian Medical University, Quanzhou, China.
Ying-Ying ZhouDepartment of Anesthesiology, The Second Affiliated Hospital, Fujian Medical University, Quanzhou, China.
He-Fan HeDepartment of Anesthesiology, The Second Affiliated Hospital, Fujian Medical University, Quanzhou, China.
Shu LinDepartment of Anesthesiology, The Second Affiliated Hospital, Fujian Medical University, Quanzhou, China.
Fujian Medical University · CNSecond Affiliated Hospital of Fujian Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuropeptide Y (NPY), which is widely distributed in the nervous system, is involved in regulating a variety of biological processes, including food intake, energy metabolism, and emotional expression. However, emerging evidence points to NPY also as a critical transmitter between the nervous system and immune system, as well as a mediator produced and released by immune cells.

Indexed as

AnimalsBody TemperatureEmotionsEnergy MetabolismGlucoseHumansImmunityImmunomodulationNeuropeptide YObesityGlucoseNeuropeptide Ybody temperaturediabetesemotionimmune cellsimmunomodulatoryneuropeptide Yobesity

Identifiers

PMID33123166
PMCPMC7573154
OpenAlexW3092168498

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.